Ramin Najafi - Net Worth and Insider Trading

Ramin Najafi Net Worth

The estimated net worth of Ramin Najafi is at least $0 dollars as of 2024-11-10. Ramin Najafi is the CEO, 10% Owner of NovaBay Pharmaceuticals Inc and owns about 0 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $0. Details can be seen in Ramin Najafi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ramin Najafi has not made any transactions after 2015-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ramin Najafi

To

Ramin Najafi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ramin Najafi owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Ramin Najafi’s form 4 insider trades.

Insider Ownership Summary of Ramin Najafi

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2015-08-20 director & Chief Executive Officer & other: Chairman

Ramin Najafi Latest Holdings Summary

Ramin Najafi currently owns a total of 1 stock. Ramin Najafi owns 0 shares of NovaBay Pharmaceuticals Inc (NBY) as of August 20, 2015, with a value of $0.

Latest Holdings of Ramin Najafi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2015-08-20 0 0.69 0

Holding Weightings of Ramin Najafi


Ramin Najafi Form 4 Trading Tracker

According to the SEC Form 4 filings, Ramin Najafi has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 0 shares on August 20, 2015, which cost Ramin Najafi around $5,640.

Insider Trading History of Ramin Najafi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ramin Najafi Trading Performance

GuruFocus tracks the stock performance after each of Ramin Najafi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ramin Najafi is -13.06%. GuruFocus also compares Ramin Najafi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ramin Najafi within 3 months outperforms 6 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ramin Najafi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ramin Najafi

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 16 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.33 LIMIT LIMIT LIMIT LIMIT LIMIT

Ramin Najafi Ownership Network

Ownership Network List of Ramin Najafi

No Data

Ownership Network Relation of Ramin Najafi

Insider Network Chart

Ramin Najafi Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Ramin Najafi is the director & Chief Executive Officer & other: Chairman of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Ramin Najafi Mailing Address

Above is the net worth, insider trading, and ownership report for Ramin Najafi. You might contact Ramin Najafi via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.